Symbol: |
PACRGL
|
Description: |
PARK2 co-regulated-like [Source:HGNC Symbol;Acc:28442]
|
Location: |
Chr4:20697905-20754530[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:145
Gene |
Compound |
Gen_sig |
Exp_pattern |
PACRGL |
NSC 41274 |
0.013 |
Up |
PACRGL |
3-BROMO-2,4,6-TRINITROTOLUENE |
0.032 |
Down |
PACRGL |
NSC 606398 |
0.034 |
Down |
PACRGL |
NSC 611274 |
0.023 |
Up |
PACRGL |
NSC 614053 |
0.004 |
Down |
PACRGL |
Naphth[2,3-d]thiazole-4,9-dione, 2-[(2-methylphenyl)amino]- |
0.031 |
Down |
PACRGL |
ANTINEOPLASTIC-625543 |
0.033 |
Down |
PACRGL |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(2-methoxy- phenyl)methylene]-, hydrochloride |
0.014 |
Down |
PACRGL |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-heptylidene-, hydrochloride |
0.007 |
Down |
PACRGL |
L-Lysine, N-[(methylamino)carbonyl]-N'-(phenylmethoxy- carbonyl)-, phenylmethyl ester |
0.014 |
Up |
PACRGL |
NSC 637128 |
0.016 |
Down |
PACRGL |
Cyclopentanone, 2-[(dimethylamino)methyl]-5- [[4-[(propionyloxy)methoxy]phenyl]methylene]-, hydrochloride |
0.027 |
Down |
PACRGL |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(3,4- dimethoxyphenyl)methylene]-, hydrochloride |
0.015 |
Down |
PACRGL |
Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)phenyl] ethylidene]-5-[(1-piperidinyl)methyl]-, hydrochloride |
0.011 |
Down |
PACRGL |
Tellurium, trichloro[1,2-hexanedioato(2-)-O,O']-, ammonium |
0.016 |
Down |
Expression pattern: Sensitivity / Resistance
Total:10 Current:3
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:26
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|